Contreras-Omaña R, Girón-Sandoval S, López-González MF, Juárez-Soto JM, Villalobos-Arreola ES, Ortega-Sánchez MA

Language: Spanish
References: 15
Page: 102-106
PDF size: 1010.60 Kb.

ABSTRACT

Acute-on-chronic liver failure, a syndrome precipitated by acute liver injury in patients with advanced cirrhosis, is associated with multiorgan dysfunction and high rates of mortality. Liver support systems have been developed in an attempt to improve survival of patients with acute-on-chronic live failure by providing a bridge until recovery of the native liver function or until transplantation. We present a case of a 47 year-old male with diagnosis of acute-onchronic liver failure secondary to mixed damage (alcohol plus acetaminophen). Within the first hours in our center, he developed significant neurological impairment, renal failure and seizures, with no response to medical treatment. Therefore, we decided to use extracorporeal liver support system (PROMETHEUS^®, Fresenius Medical Care AG, Bad Homburg, Germany ). The patient received four sessions prior to liver transplantation.

REFERENCES

1. Stadlbauer V, Davies N, Sen S. Artificial Liver Support Systems in the Management of Complications of Cirrhosis. Semin Liver Dis 2008;28:96–109.

2. Lok S.F.A. Impact of Acute Insults on the Natural History of Cirrhosis (“Acute-on-Chronic Liver Failure”) Viral Hepatitis.In: García-Tsao G, Kamath P, editores. Cirrhosis: current challenges and future directions. 1ª, San Francisco, Ca. USA: AASLD; 2011: 81-87.

3. Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut 2009;58:1690–1702.

4. Hassanein T, Schade R, Hepbur I. Acute-on-chronic liver failure: extracorporeal liver assist devices. Current Opinion in Critical Care 2011; 17:195–203.

5. Cadena Ariza F, Carmona Serda LF, Quintero IF, cols. Sistemas de soporte hepático extracorpóreo. Rev Colomb Anestesiol 2011; 39:528-543.

6. Atienza Merino G. Evaluación de los sistemas de soporte hepático extracorpóreo en el tratamiento de la insuficiencia hepática. Gastroenterol Hepatol 2010; 33: 352-362.

7. B Keeffe E. Insuficiencia hepática aguda. Rev Gastroenterol Mex 2005; 70:56-62.

8. Jalan R, Gines P, Olson JC, et al. Acute on chronic liver failure. J Hepatol 2012; 57:1336-1348.

9. Tan HK. Molecular Adsorbent Recirculating System (MARS). Ann Acad Med Singapore. 2004;33:329-335.

10. Karvellas JC, Gibney N, Kutsogiannis D, et al. Bench-to-bedside review: Current evidence for extracorporeal albumin dialysis systems in liver failure. Critical Care 2007, 11:215.

11. Rosa Diez G, Gadano A. Sistemas no biológicos de soporte hepático artificial: ¿En qué consisten y qué rol ocupan en la actualidad?. Acta Gastroenterol Latinoam 2012; 42:135-144.

12. Sen S, Williams R, Jalan R. Emergin Indications for Albumin Dialysis. Am J Gastroenterol 2005;100:468- 475.

13. Polson J, Lee W. AASLD Position Paper: The Management of Acute Liver. HEPATOLOGY, 2005;41:1179-1107.

14. Sentürk E, Esen F, Ozcan P. The Treatment of Acute Liver Failure with Fractionated Plasma Separation and Adsorption System: Experience in 85 Applications. Journal of Clinical Apheresis 2010;25:195–201.

15. Katoonizadeh A, Laleman W, Verslype C, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010 59: 1561- 1569.